Kerusso Capital Management’s Pfizer PFE Stock Holding History

Kerusso Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.23M	Buy	148,251 +74,554	+101%	+$1.98M	1.38%	44
2026 Q2	$1.77M	Sell	73,697 -59,729	-45%	-$1.56M	0.65%	56
2026 Q1	$3.75M	Sell	133,426 -9,472	-7%	-$252K	1.88%	25
2025 Q4	$3.56M	Buy	142,898 +34,848	+32%	+$879K	1.64%	37
2025 Q3	$2.75M	Sell	108,050 -6,260	-5%	-$155K	1.69%	34
2025 Q2	$2.77M	Buy	114,310 +61	+0.1%	+$1.42K	1.71%	27
2025 Q1	$2.9M	Buy	114,249 +2,920	+3%	+$76.4K	1.84%	30
2024 Q4	$2.95M	Buy	111,329 +248	+0.2%	+$6.73K	1.89%	22
2024 Q3	$3.21M	Buy	111,081 +6,759	+6%	+$197K	2.04%	16
2024 Q2	$2.92M	Buy	+104,322	New	+$2.87M	2.12%	17

Other funds holding PFE

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Kerusso Capital Management's PFE Position: Q3 2026 in Review

Kerusso Capital Management increased its Pfizer (PFE) stake by 101% in Q3 2026, buying an estimated $1.98M and bringing the position to 148,251 shares worth $4.23M. The position accounts for 1.38% of the portfolio, ranked #44.

Kerusso Capital Management first reported a position in PFE in Q2 2024 and has held it in 10 quarters since. 2,002 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

Kerusso Capital Management held 148,251 shares of Pfizer worth $4.23M as of Q3 2026.
Kerusso Capital Management bought 74,554 Pfizer shares in Q3 2026, an estimated $1.98M.
Pfizer made up 1.38% of Kerusso Capital Management's portfolio in Q3 2026, its #44 holding.
Kerusso Capital Management first reported a position in Pfizer in Q2 2024 and has held it in 10 quarters since.
2,002 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Kerusso Capital Management's 13F filing for Q3 2026, filed 27 Oct 2026.